Skip to main content
. Author manuscript; available in PMC: 2010 Jul 14.
Published in final edited form as: Calcif Tissue Int. 2006 Aug 15;79(2):112–117. doi: 10.1007/s00223-006-0074-7

Table 1.

Growth and skeletal parameters at 4, 8, and 12 weeks of age

Age (weeks)

4 8 12



Parameter WT FHL2 KO WT FHL2 KO WT FHL2 KO
Body weight (g)
  Female 12.82±0.71 11.80±0.55*, ** 19.28±0.37** 17.76±0.28*, **, *** 22.12±0.50** 20.90±0.56**
  Male 15.28±0.43 13.17±0.82* 23.96±0.39 23.23±0.62* 27.80±0.91 27.25±0.93
Body length (mm)
  Female 73.40±2.54 73.33±1.26   85.8±1.20** 84.83±1.22** 89.20±1.36** 89.00±1.29**
  Male 77.60±1.21 73.67±1.52 93.20±0.37 90.83±1.78 95.00±0.63 95.00±1.75
Femur BMC (mg)
  Female   6.54±0.49   5.83±0.31*   16.6±0.93 12.07±0.83*** 19.48±0.22 17.27±0.74***
  Male   7.67±0.42   6.52±0.50* 15.63±1.01 16.37±1.58 19.27±0.42 20.43±1.57
Femur BMD (mg/cm2)
  Female 42.26±1.29 38.90±0.46 63.80±1.74** 55.53±2.26**, *** 72.02±1.03 67.12±1.49***
  Male 41.20±2.15 40.17±1.28 65.03±1.95 67.18±4.56 68.72±1.92 77.02±5.24
Tibia BMC (mg)
  Female   7.60±0.49   7.50±0.43* 16.74±1.01 14.07±0.56*** 18.90±0.61 16.88±1.12
  Male 10.17±0.48   7.08±0.84* 16.10±0.28 17.02±1.10 18.85±0.42 19.90±1.06
Tibia BMD (mg/cm2)
  Female 34.58±1.13 33.00±1.16 53.00±2.09 47.82±0.95*** 58.10±1.91 54.57±3.11
  Male 35.85±1.30 33.28±1.95 51.62±1.94 53.57±2.14 58.38±1.52 60.57±2.82
*

Significant main effect for treatment at P < 0.05

**

Significant main effect for gender at P < 0.05

***

Significant treatment effect for female mice at P < 0.05; n = 5 or 6 in each treatment group (n = 23)